Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avisa Diagnostics
Malvern, Pennsylvania, United States
- Ownership
- Private
- Employees
- ~2
- Development stage
- Other
01
Overview
Avisa Diagnostics completed early clinical proof-of-concept and is preparing for pivotal FDA-regulated trials in bronchiectasis and VAP; the BreathTest detects bacterial pulmonary infections through a rapid, non-invasive breath assay using a proprietary labeled drug substrate.
- Therapeutic areas
- PulmonologyInfectious Diseases
- Modalities
- DeviceDrug/device combination
- Industry
- Metabolite Diagnostics
02
Partnerships
GEM Yield Bahamas Ltd.GEM Global Yield LLC SCS
Beyond the preview
Go deeper on Avisa Diagnostics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Avisa Diagnostics.